Charles River Laboratories
Rodrigo Munguía Fabela is a seasoned professional in the biotechnology and gene therapy sectors, currently serving as Senior Commercial Development Manager at Charles River Laboratories since May 2022. Prior roles include Commercial Excellence Manager and Senior Inside Business Specialist at the same company, as well as Commercial Operations and Business Development Lead and European Head of Business Development at Viralgen Vector Core from August 2019 to May 2022. Rodrigo co-founded C-MedTec in late 2018 and also worked as a Business System Analyst in Finance at Viralgen earlier that year. Education includes multiple Master’s degrees in Bioengineering, Medical Engineering, and Gene Therapy from prestigious institutions such as EPFL, KTH Royal Institute of Technology, and City St George’s, University of London.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.